弥漫性体部血管角皮瘤一例_West China Medical Journal

Authors：

李玲玲 ,  张佩莲

Corresponding author：

张佩莲, Email: mzczpl1968@163.com

Keywords：

弥漫性; 血管角皮瘤; a-苯乳糖苷酶 A

DOI：

10.7507/1002-0179.201606133

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 李玲玲, 张佩莲. 弥漫性体部血管角皮瘤一例. West China Medical Journal, 2017, 32(6): 961-961. doi: 10.7507/1002-0179.201606133 Copy

1.	Ramaswami U, Whybra C, Parini R, et al. Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta Paediatr, 2006, 95(1): 86-92.
2.	Paliouras C, Aperis G, Lamprianou F, et al. Control of proteinuria with increased doses of agalsidase alfa in a patient with Fabry disease with atypical genotype-phenotype expression. Nefrologia, 2015, 35(6): 578-581.
3.	Arends M, Hollak CE, Biegstraaten M. Quality of Life in patients with Fabry disease: a systematic review of the literature. Orphanet J Rare Dis, 2015, 10: 77.
4.	Germain DP, Charrow J, Desnick RJ, et al. Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease. J Med Genet, 2015, 52(5): 353-358.
5.	Pieroni M, Camporeale A, Della Bona R, et al. Progression of fabry cardiomyopathy despite enzyme replacement therapy. Circulation, 2013, 128(15): 1687-1688.